Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Latin America (Supplemental) | 2023

  • The Latin American heart valve device market will be driven by expanding patient pool and improving access to treatment in the Latin American countries. The strong growth through 2031 will be primarily fueled by rapid adoption of THV devices and positive results from THV device clinical trials. Furthermore, novel devices and device types will continue to emerge in the coming years and access new patient populations, generating continued growth in this market.

    This Medtech 360 Report provides high-level market metrics for heart valve devices in Latin America markets, including country-level data for major countries and aggregate data for the rest of the Latin America region, from 2019 through 2031.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…